Q32 Bio (QTTB) grants CFO 53,250 performance-based stock units
Rhea-AI Filing Summary
Q32 Bio Inc. officer Lee Kalowski, its CFO and President, reported an acquisition of 53,250 shares of common stock on July 16, 2026, via a grant of performance-based restricted stock units (PSUs). Each PSU represents a contingent right to one share, and his direct holdings increased to 142,443 shares.
The PSUs were granted on July 6, 2026 and are tied to a performance-based condition linked to the closing of a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026, and a time-based condition under which they vest in equal quarterly installments over three years from July 1, 2026, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 53,250 shares
Net Buy
1 txn
Insider
Kalowski Lee
Role
CFO and President
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 53,250 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 142,443 shares (Direct)
Footnotes (1)
- F1. Represents shares of Issuer common stock underlying performance-based restricted stock units ("PSUs") granted on July 6, 2026, which vested on July 16, 2026 with respect to a performance-based condition, upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. Such PSUs are also subject to a time-based condition, which provides that the PSUs shall vest in equal quarterly installments over three years from July 1, 2026, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. Each PSU represents a contingent right to receive one share of Issuer common stock.
Key Figures
Equity grant: 53,250 shares
Holdings after transaction: 142,443 shares
Grant price per share: $0.0000 per share
+2 more
5 metrics
Equity grant
53,250 shares
Shares of common stock underlying PSUs acquired on July 16, 2026
Holdings after transaction
142,443 shares
Directly held by Lee Kalowski following the PSU-related award
Grant price per share
$0.0000 per share
Reported transaction price per share for the PSU-related common stock
Performance financing threshold
$100,000,000
Gross proceeds financing level tied to the PSUs’ performance-based condition
Time-based vesting period
3 years
PSUs vest in equal quarterly installments over three years from July 1, 2026
Key Terms
performance-based restricted stock units, gross proceeds, time-based condition, contingent right
4 terms
performance-based restricted stock units financial
"Represents shares of Issuer common stock underlying performance-based restricted stock units"
Performance-based restricted stock units are a type of employee equity award that converts into company shares only if predefined financial or operational targets are met over a set period. Think of it like a bonus check that becomes stock only when specific goals are hit; it ties pay to results, aligning managers’ incentives with shareholders. Investors care because these awards affect future share count, executive incentives, and signal how management’s success will be measured and rewarded.
gross proceeds financial
"upon achievement of the closing of a financing of at least $100,000,000 in gross proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.
time-based condition financial
"Such PSUs are also subject to a time-based condition, which provides that the PSUs shall vest"
contingent right financial
"Each PSU represents a contingent right to receive one share of Issuer common stock"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did Q32 Bio (QTTB) CFO Lee Kalowski report?
Lee Kalowski reported the acquisition of 53,250 shares of Q32 Bio common stock on July 16, 2026, through performance-based restricted stock units. Each PSU equals one share of common stock, increasing his direct holdings to 142,443 shares after this award.
What are the performance conditions on Lee Kalowski’s Q32 Bio (QTTB) PSUs?
The PSUs are linked to a performance-based condition tied to closing a financing of at least $100,000,000 in gross proceeds on or before December 31, 2026. Meeting this financing condition is required in addition to the separate time-based vesting schedule.
How do the time-based vesting terms work for Q32 Bio (QTTB) PSUs granted to Lee Kalowski?
The PSUs are subject to a time-based condition under which they vest in equal quarterly installments over three years starting July 1, 2026. Vesting is contingent on the reporting person’s continued service through each applicable vesting date.
Was the Q32 Bio (QTTB) Form 4 transaction under a Rule 10b5-1 trading plan?
The Form 4 indicates the Rule 10b5-1 checkbox is not marked, so this award was not reported as made pursuant to a Rule 10b5-1 trading plan. It reflects a compensation-related grant rather than an open-market trade.